GKOS 📈 Glaukos - Overview

Glaukos Corporation is a prominent player in the ophthalmic pharmaceutical and medical technology sector, dedicated to developing innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company's product portfolio includes the iStent and iStent inject W micro-bypass stents, which are designed to enhance aqueous humor outflow and are typically inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. By leveraging its expertise in micro-invasive glaucoma surgery, Glaukos aims to provide effective treatment options for patients with glaucoma and other eye disorders.

The company's pipeline is robust, with several promising products in various stages of development. For instance, the iStent Infinite is indicated for use in patients with glaucoma that is uncontrolled by prior medical and surgical therapy, offering a new treatment avenue for those with limited options. Additionally, the iDose TR is an intracameral procedural pharmaceutical therapy that has shown potential in reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. These products, along with others in the pipeline, demonstrate Glaukos' commitment to addressing the complex needs of patients with eye diseases.

Glaukos Corporation's commercial strategy involves a combination of direct sales and distribution partnerships, both in the United States and internationally. This approach enables the company to effectively reach a broad customer base, including ophthalmologists, optometrists, and other healthcare professionals. With a strong foundation in research and development, a growing product portfolio, and a well-established commercial presence, Glaukos is well-positioned to drive growth and expansion in the global ophthalmic market. Founded in 1998 and headquartered in Aliso Viejo, California, the company has established itself as a key player in the health care equipment sector, with a focus on delivering innovative solutions for patients with eye diseases.